The big question in suicide prevention is how we can reach people at risk who would not normally seek professional help.

The addition of Tecentriq to BCG therapy did not significantly improve outcomes for patients with non–muscle-invasive bladder ...

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

The burden of cognitive decline is growing, affecting many people worldwide and placing a substantial strain on health-care ...